Elite Pharmaceuticals, Inc. (ELTP) Operating margin 2017–2026
Elite Pharmaceuticals, Inc. (ELTP) operating margin by fiscal year — reported operating income divided by reported revenue.
33.0%FY2026 · since FY2017: -76.3% → 33.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | 33.0% | +9.7 pp |
| FY2025 | 23.3% | +4.3 pp |
| FY2024 | 19.1% | +8.3 pp |
| FY2023 | 10.8% | -5.0 pp |
| FY2022 | 15.7% | +7.4 pp |
| FY2021 | 8.3% | +21.0 pp |
| FY2020 | -12.7% | +108.3 pp |
| FY2019 | -121.0% | +0.3 pp |
| FY2018 | -121.4% | -45.0 pp |
| FY2017 | -76.3% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice